Rocky Mountain Cancer Centers, LLP is a clinical research site located in Lone Tree, Colorado, United States 80124.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centers, LLP has participated in 11 clinical trials with 8 currently active.
Therapeutic areas: Breast Cancer, Colorectal Neoplasms, Renal Cell Carcinoma.
Sponsors: Stemline Therapeutics, Inc., Seagen, a wholly owned subsidiary of Pfizer, HiberCell, Inc..
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centers, LLP has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centers, LLP has 11 clinical trials on record, with 8 currently active. Their work covers Breast Cancer, Colorectal Neoplasms, Renal Cell Carcinoma.
Yes — Rocky Mountain Cancer Centers, LLP holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.